glp 1 and pancreas Not Gut Mediates the GLP-1-Induced Glucoincretin Effect: Cell Metabolism Science Behind GLP 1 GIP

doi: 10.1111/dom.12386

Chemical analogues of GLP-1 are currently approved for the treatment of type 2 diabetes (T2D) and obesity 3,4

The quantitative bias analysis suggested that moderate unmeasured confounding could potentially explain away an HR of 0.86 observed with SGLT2 inhibitors versus DPP4 inhibitors, whereas stronger unmeasured confounding is needed to explain away larger HRs observed in as-treated analyses (Supplementary Fig

Tirzepatide once weekly for the treatment of obesity in people with type 2 diabetes (surmount-2): A double-blind, randomised, multicentre, placebo-controlled, phase 3 trial

Nephrology Dialysis Transplantation